PRCT240517P40000
- 0.80
- 0.000.00%
PROCEPT BioRobotics Newsroom
PROCEPT BioRobotics (NASDAQ:PRCT) Has Debt But No Earnings; Should You Worry?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solu
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Elevation Oncology (ELEV)
PROCEPT BioRobotics Is Maintained at Buy by TD Cowen
PROCEPT BioRobotics Is Maintained at Buy by TD Cowen
PROCEPT BioRobotics Price Target Raised to $75.00/Share From $65.00 by TD Cowen
PROCEPT BioRobotics Price Target Raised to $75.00/Share From $65.00 by TD Cowen
Piper Sandler: Maintaining the PROCEPT BioRobotics (PRCT.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $67.00 to $75.00.
Piper Sandler: Maintaining the PROCEPT BioRobotics (PRCT.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $67.00 to $75.00.
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $75
Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $67 to $75.
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and PROCEPT BioRobotics (PRCT)
Procept BioRobotics Insider Sold Shares Worth $1,916,428, According to a Recent SEC Filing
Alaleh Nouri, Executive Vice President, Chief Legal Officer, Corporate Secretary, on May 03, 2024, sold 30,432 shares in Procept BioRobotics (PRCT) for $1,916,428. Following the Form 4 filing with the
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men With Benign Prostatic Hyperplasia
Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy's potential to become the new standard of care in BPH f
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price Targets
Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics(PRCT.US) Director Sells US$1.2 Million in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Director Krummel Thomas M sold 20,000 shares of common stock on May 1, 2024 at an average price of $60 for a total value of $1.2 million.Source: Announcement What is sta
PROCEPT BioRobotics(PRCT.US) Officer Sells US$1.92 Million in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Officer Nouri Alaleh sold 30,432 shares of common stock on May 3, 2024 at an average price of $62.97 for a total value of $1.92 million.Source: Announcement What is stat
Form 144 | PROCEPT BioRobotics(PRCT.US) Officer Proposes to Sell 1.92 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $PROCEPT BioRobotics(PRCT.US)$ Officer Alaleh Nouri intends to sell 30,432 shares of its common stock on May 3, with a total market value of approximately $1.92 million.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
PROCEPT BioRobotics Engages Investors With Company Insights
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
Truist Securities: Maintains PROCEPT BioRobotics (PRCT.US) rating, adjusted from buy to buy rating, and adjusted target price from $63.00 to $72.00.
Truist Securities: Maintains PROCEPT BioRobotics (PRCT.US) rating, adjusted from buy to buy rating, and adjusted target price from $63.00 to $72.00.